Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q80932376)
Watch
English
Tocilizumab for rheumatoid and juvenile idiopathic arthritis
scientific article published on 01 March 2008
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
title
Tocilizumab for rheumatoid and juvenile idiopathic arthritis
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
main subject
juvenile rheumatoid arthritis
1 reference
based on heuristic
inferred from title
tocilizumab
1 reference
based on heuristic
inferred from title
author name string
Tim Bongartz
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
language of work or name
English
0 references
publication date
1 March 2008
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
volume
371
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
issue
9617
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
page(s)
961-963
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
cites work
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin 6: from bench to bedside
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prediction of Coronary Heart Disease Using Risk Factor Categories
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960428-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(08)60428-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
PubMed publication ID
18358909
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18358909
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18358909%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit